Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / teva pharmaceutical 6 takeaways from q1 2024 earning

TEVA - Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results

Teva Pharmaceutical Industries Limited American Depositary Shares

2024-05-09 08:15:00 ET

Summary

  • Teva Pharmaceutical stock has been trending higher since October 2023, closing at nearly $16.00.
  • The company reported strong first-quarter results, with increased revenue and growth in key metrics.
  • Teva has a positive business outlook for 2024, with a forecast for adjusted EBITDA of up to $5.0 billion and potential blockbuster drugs in its pipeline.

Since October 2023, shares of Teva Pharmaceutical ( TEVA ) trended higher from around $8.00 to close at $15.74. In addition to earning a bullish “Buy” quant rating in early April, what are the fundamentals that changed following Teva’s first-quarter results?...

For further details see:

Teva Pharmaceutical: 6 Takeaways From Q1 2024 Earnings Results
Stock Information
Company Name: Teva Pharmaceutical Industries Limited American Depositary Shares
Stock Symbol: TEVA
Market: NYSE
Website: tevapharm.com
Menu
TEVA TEVA Quote TEVA Short TEVA News TEVA Articles TEVA Message Board
Get TEVA Alerts

News, Short Squeeze, Breakout and More Instantly...